During the past decade, St. John's Institute of Dermatology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. John's Institute of Dermatology" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "St. John's Institute of Dermatology" are "Lymphoma, T-Cell, Cutaneous" (3 trials), "Mycosis Fungoides" (2 trials), "Sezary Syndrome" (2 trials), "Chronic Plaque Psoriasis" (1 trials) and "Disease, Hodgkin" (1 trials). Many other conditions were trialed in "St. John's Institute of Dermatology" in a lesser frequency.

Most popular intervention types in "St. John's Institute of Dermatology" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ONTAK" (2 trials), "Alefacept" (1 trials), "Best practice skin care advice booklet" (1 trials), "Experimental (Doublebase Gel® or Diprobase Cream®)" (1 trials) and "brentuximab vedotin" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. John's Institute of Dermatology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "St. John's Institute of Dermatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in St. John's Institute of Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. John's Institute of Dermatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".